CCA
IRON icon

Cygnus Capital Advisors’s Disc Medicine IRON Stock Holding History

Cygnus Capital Advisors’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-502
Closed -$40 – 150
2025
Q4 		$40 Buy
+502
New +$42.4K 0.03% 69

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Cygnus Capital Advisors's IRON Position: Q1 2026 in Review

Cygnus Capital Advisors sold out of Disc Medicine (IRON) in Q1 2026, closing a stake of 502 shares — an estimated $40 sold.

Cygnus Capital Advisors first reported a position in IRON in Q4 2025 and held it in 1 quarter. The position peaked at $40 in Q4 2025. 203 funds tracked by Wall St. Rank hold IRON as of Q1 2026.

  • Cygnus Capital Advisors reported no remaining Disc Medicine position as of Q1 2026 after selling out during the quarter.
  • Cygnus Capital Advisors sold 502 Disc Medicine shares in Q1 2026, an estimated $40.
  • Cygnus Capital Advisors first reported a position in Disc Medicine in Q4 2025 and held it in 1 quarter.
  • Cygnus Capital Advisors's Disc Medicine position peaked at $40 in Q4 2025.
  • 203 funds tracked by Wall St. Rank held Disc Medicine as of Q1 2026.

Based on Cygnus Capital Advisors's 13F filing for Q1 2026, filed 13 May 2026.